← Back to Clinical Trials
Recruiting NCT07011420

NCT07011420 Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07011420
Status Recruiting
Phase
Sponsor Liberating Technologies, Inc.
Condition Amputation
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2025-10
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Experimental socket with 4 untargeted channels activeExperimental socket with 8 untargeted channels activeExperimental socket with up to 16 untargeted channels active

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2025-10 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing a physical prosthesis. The specific aims of this study are: 1. To evaluate the effect of changing untargeted myoelectric channel count on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test. 2. To evaluate the effect of changing myoelectric channel targeting of a fixed number of myoelectric channels on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test. Researchers will perform a randomized crossover study to compare system configurations with different number of sensor channels and with various strategies for sensor placement on the limb. Participants will be assigned to a random test sequence that includes the following four different EMG channel conditions: Condition A: 4 untargeted channels Condition B: 8 untargeted channels Condition C: Up to 16 untargeted channels Condition D: 8 targeted channels Researchers will evaluate the effects of changing myoelectric channel counts on the functional prosthesis performance of individuals with transradial limb loss via functional outcome measures. Participants will: * Attend up to 5 in-lab sessions that are expected to last 4 hours. * Conduct site visits every 1-2 weeks to complete functional and self reported outcome measures with each condition. * Play virtual games with the Coapt Cuff for 15 minutes a day, 3 days a week in between visits.

Eligibility Criteria

Inclusion Criteria: * Unilateral transradial level limb absence * Current or past user of myo-electric controlled prostheses * Six months or more post-amputation * Have adequate limb length such that a wrist rotation device can fit in the check socket * Well-fitting socket as determined by a Socket-Comfort Score of 6 or above * Capable of wearing and operating a prosthesis with a wrist rotator and multi-articulating hand * Capable of understanding and following multi-step instructions and completing the tasks as described * English speaking Exclusion Criteria: * Significant new injury that would prevent use of a prosthesis: The ability to consistently wear a prosthesis and perform activities of daily living and specific performance tasks is necessary to evaluate the relative benefits of the interventions. * Cognitive impairment sufficient to adversely affect understanding of or compliance with study requirements, ability to communicate experiences, or ability to give informed consent: The ability to understand and comply with requirements of the study is essential for the study to generate useable, reliable data. The ability to obtain relevant user feedback through questionnaires and informal discussion adds significant value to this study.

Contact & Investigator

Central Contact

Brianna Rozell

✉ brianna.rozell@liberatingtech.com

📞 774-233-0876

Principal Investigator

Todd Farrell, PhD

PRINCIPAL INVESTIGATOR

Liberating Technologies, Inc.

Frequently Asked Questions

Who can join the NCT07011420 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07011420 currently recruiting?

Yes, NCT07011420 is actively recruiting participants. Contact the research team at brianna.rozell@liberatingtech.com for enrollment information.

Where is the NCT07011420 trial being conducted?

This trial is being conducted at Chicago, United States, Holliston, United States.

Who is sponsoring the NCT07011420 clinical trial?

NCT07011420 is sponsored by Liberating Technologies, Inc.. The principal investigator is Todd Farrell, PhD at Liberating Technologies, Inc.. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology